Advanced search
Start date
Betweenand
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Micromethod for plasma cefuroxime quantification through high performance liquid chromatography: application to the prophylaxy of patients submitted to cardiac surgery

Full text
Author(s):
Jorge Willian Leandro Nascimento [1] ; Célia Etsuco Omosako [2] ; Maria José Carmona [3] ; José Otávio Auler Junior [4] ; Silvia Regina Cavani Jorge Santos [5]
Total Authors: 5
Affiliation:
[1] Universidade de São Paulo. Faculdade de Ciências Farmacêuticas. Departamento de Farmácia
[2] Universidade de São Paulo. Faculdade de Medicina. Instituto do Coração Hospital das Clínicas
[3] Universidade de São Paulo. Faculdade de Medicina. Instituto do Coração Hospital das Clínicas
[4] Universidade de São Paulo. Faculdade de Medicina. Instituto do Coração Hospital das Clínicas
[5] Universidade de São Paulo. Faculdade de Ciências Farmacêuticas. Departamento de Farmácia
Total Affiliations: 5
Document type: Journal article
Source: Revista Brasileira de Ciências Farmacêuticas; v. 39, n. 3, p. 265-272, 2003-09-00.
Abstract

An improved, simple, selective and sensitive micromethod based on HPLC-UV is described to determine cefuroxime plasma levels, a second generation cephalosporin. Once changes on pharmacokinetics of drugs in patients submitted to heart surgery with cardiopulmonary bypass and hypothermia (CPB-H) were reported previously, the objective of the present study was to investigate cefuroxime plasma levels for antimicrobial prophylaxis of infections in those patients after surgery using HPLC-UV. Only 200 µL of plasma were required, and cefuroxime was determined by a chromatographic method using reversed phase system, after a simple clean up of plasma samples. Peaks monitored at 280 nm were eluted isocratically at 12.5 min (cefuroxime) and at 4.0 min (vancomicyn, internal standard,) from a 4 µm, NovaPak column (150 x 3.9 mm) using a binary mobile phase at flow rate 0.8 mL/min, consisting of 0.375 M acetate buffer, pH 5,0 and acetonitrile, 96:4 (v/v). The method validated with basis of parameters evaluated for the confidence limits of cefuroxime measurements in spiked blank plasma, presents 0.1 µg/mL sensitivity, 0.2 - 200 µg/mL linearity, (r² 0.998), systematic error of 98.2% and 96.9% (intra- and interday accuracy), intra- and interday precision (CV %: 3.2 % and 4.2 %). A good stability and high percentage of recovery (99.2%) were obtained. Patients received cefuroxime 6 g i.v. bolus (1,5 g, 4 times in 24 hours), showed in the first postoperative day plasma levels of 108.0 µg/mL (zero), 32.8 µg/mL (3rd h), 9.9 µg/mL (6th h), 3.4 µg/mL (9th h) and 0.8 µg/mL (12th h), after the last dose. (AU)